8Suppliers
4Customers
3Debt Items
20Related Chains

Source-Backed Evidence Depth

GlucoTrack, Inc. (GCTK) is shown with relationship data already present in ChainSifter's database. Counts below come from stored supply-chain records and filing/source URLs where available; missing source URLs are not filled in or estimated.

25Total relationships
3Distinct source URLs
21High confidence
0.882Average confidence
2026-09-13Latest database update
ChainSifter does not infer unreported suppliers, customers, ownership, acquisitions, debt exposure, revenue dependency, or future supply-chain events on this public page.

GlucoTrack, Inc. Suppliers

TickerNameConfidenceEvidence
ARMISTICE-CAPITAL-MASTER-FUND-LTD ARMISTICE-CAPITAL-MASTER-FUND-LTD 92% On December 29, 2025, we entered into a Securities Purchase Agreement (the “Securities Purchase Agreement”) with Armistice Capital Master Fund Ltd. (also referred to herein as the “Investor”) for a p…
INVESTOR INVESTOR 92% The Company entered into a Registration Rights Agreement with the Investor
SIXTH-BOROUGH-CAPITAL-FUND-LP SIXTH-BOROUGH-CAPITAL-FUND-LP 92% Under the terms of the ELOC, the Company has the right, but not the obligation, to sell to Sixth Borough, and Sixth Borough is obligated to purchase, up to $ 20.0 million of the Company’s Common Stock
DAWSON-JAMES DAWSON-JAMES 90% Dawson James acted as the placement agent for the offerings pursuant to a placement agency agreement, dated February 4, 2025, by and between the Company and Dawson James
PAUL-GOODE PAUL-GOODE 90% In consideration for the sale by Dr. Goode of the Purchased Assets to the Company, the Company paid to Dr. Goode cash in the amount of one dollar
MASIMO-CORPORATION MASIMO-CORPORATION 80% Ms. Carter currently serves as the SVP of Corporate Development and Strategic Finance for Masimo Corporation
MAYO-COLLABORATIVE-SERVICES MAYO-COLLABORATIVE-SERVICES 80% From 2023 to 2025, she served as the Chief Financial Officer for the Mayo Collaborative Services, at the Mayo Clinic
MEDTRONIC MEDTRONIC 80% From 2012 until March of 2023, she held various senior roles with Medtronic

GlucoTrack, Inc. Customers

TickerNameConfidenceEvidence
ABT Abbott Laboratories 72% Reciprocal relationship from ABT graph: Reciprocal relationship from GCTK graph: ability to commercialize our products. 12 The Privacy Provisions of HIPAA In the United States, HIPAA, among other thi…
ABT Abbott Laboratories 72% ability to commercialize our products. 12 The Privacy Provisions of HIPAA In the United States, HIPAA, among other things, protects the privacy and security of individually identifiable health inform…
SENS Senseonics Holdings, Inc. 72% Reciprocal relationship from SENS graph: Reciprocal relationship from GCTK graph: surements using a glucometer) are required for calibration. For the Medtronic Guardian 4 system, there is a 2-hour wa…
SENS Senseonics Holdings, Inc. 72% surements using a glucometer) are required for calibration. For the Medtronic Guardian 4 system, there is a 2-hour warm-up period; after that period, no fingersticks are required for calibration when…

GlucoTrack, Inc. Debt Obligations

InstrumentDescriptionConfidenceEvidence
GCTK-DEBT Debt stack $3.6M 90% Market cache reports total debt of $3.6M.
GCTK-DEBT-9734 Xbrl Convertible 90% xbrl convertible detail from xbrl 2024-12-31.
GCTK-DEBT-9733 Warrants outstanding: 5000 90% xbrl warrant detail from xbrl 2025-12-31.

GlucoTrack, Inc. Acquisitions

No acquisitions on recordNo completed or pending acquisitions found in our database for GlucoTrack, Inc..

GlucoTrack, Inc. Ownership

HolderNameConfidenceEvidence
GCTK-OWNER-OSAIC-HOLDINGS-INC Osaic Holdings Inc. 95% 13F/ownership overlay lists Osaic Holdings Inc.; shares held 1; as of 2025-12-31.
GCTK-OWNER-BOOTHBAY-FUND-MANAGEMENT-LLC Boothbay Fund Management, LLC 95% 13F/ownership overlay lists Boothbay Fund Management, LLC; shares held 13,525; ownership 1.34%; value $13,392; as of 2025-12-31.
GCTK-OWNER-BANK-OF-AMERICA-CORPORATION Bank of America Corporation 95% 13F/ownership overlay lists Bank of America Corporation; shares held 28; value $27; as of 2025-12-31.
GCTK-OWNER-NEWBRIDGE-FINANCIAL-SERVICES-GROUP-INC Newbridge Financial Services Group, Inc. 95% 13F/ownership overlay lists Newbridge Financial Services Group, Inc.; shares held 34; value $33; as of 2025-12-31.
GCTK-OWNER-ALERUS-FINANCIAL-NA Alerus Financial NA 95% 13F/ownership overlay lists Alerus Financial NA; shares held 4,000; ownership 0.40%; value $3,960; as of 2025-12-31.
GCTK-OWNER-TOWER-RESEARCH-CAPITAL-LLC-TRC Tower Research Capital LLC (TRC) 95% 13F/ownership overlay lists Tower Research Capital LLC (TRC); shares held 425; ownership 0.04%; value $420; as of 2025-12-31.
GCTK-OWNER-MORGAN-STANLEY Morgan Stanley 95% 13F/ownership overlay lists Morgan Stanley; shares held 1; as of 2025-12-31.
GCTK-OWNER-UBS-GROUP-AG UBS Group AG 95% 13F/ownership overlay lists UBS Group AG; shares held 119; ownership 0.01%; value $117; as of 2025-12-31.
GCTK-OWNER-IKARIAN-CAPITAL-LLC Ikarian Capital, LLC 95% 13F/ownership overlay lists Ikarian Capital, LLC; shares held 45,830; ownership 4.53%; value $45,380; as of 2025-12-31.
GCTK-OWNER-SBI-SECURITIES-CO-LTD SBI Securities Co., Ltd. 95% 13F/ownership overlay lists SBI Securities Co., Ltd.; shares held 9; value $8; as of 2025-12-31.

GlucoTrack, Inc. Extended Supply Chain Network

TickerNameChain IndexHopsRelationship Types
NBP NovaBridge Biosciences 100.00 2
NSPR InspireMD, Inc. 100.00 2
ITGR Integer Holdings Corporation 100.00 2
IINN Inspira Technologies Oxy B.H.N. Ltd. 100.00 2
NVS Novartis AG 100.00 2
MTLS Materialise NV 100.00 2
IVA Inventiva S.A. 100.00 2
GIFLF Grifols, S.A. 100.00 2
ABT Abbott Laboratories 100.00 1 ['customer']
ALVO Alvotech 100.00 2
PSNL Personalis, Inc. 100.00 2
GRFS Grifols, S.A. 100.00 2
AORT Artivion, Inc. 100.00 2
FLGT Fulgent Genetics, Inc. 100.00 2
GRAL GRAIL, Inc. 100.00 2
GIKLY Grifols, S.A. 100.00 2
SVA Sinovac Biotech Ltd. 100.00 2
EXAS Exact Sciences Corp 100.00 2
GIFOF Grifols, S.A. 100.00 2
NVEC NVE Corporation 100.00 2
🔐
GCTK
Unlock GCTK Supply Chain Data
Verified relationships include:
ARMISTICE-CAPITAL-MASTER-FUND-LTDARMISTICE-CAPITAL-MASTER-…Supplier92%
INVESTORINVESTORSupplier92%
ABTAbbott LaboratoriesCustomer72%
ABTAbbott LaboratoriesCustomer72%
+21 more relationships locked
Subscribe — View plans →